title: Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy.
authors.affiliation: Erasmus MC, Thoraxcenter, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
authors.forename: Francesco
authors.initials: F
authors.lastname: Saia
authors.forename: Pedro A
authors.initials: PA
authors.lastname: Lemos
authors.forename: Georgios
authors.initials: G
authors.lastname: Sianos
authors.forename: Muzaffer
authors.initials: M
authors.lastname: Degertekin
authors.forename: Chi-Hang
authors.initials: CH
authors.lastname: Lee
authors.forename: Chourmouzios A
authors.initials: CA
authors.lastname: Arampatzis
authors.forename: Angela
authors.initials: A
authors.lastname: Hoye
authors.forename: Kengo
authors.initials: K
authors.lastname: Tanabe
authors.forename: Evelyn
authors.initials: E
authors.lastname: Regar
authors.forename: Willem J
authors.initials: WJ
authors.lastname: van der Giessen
authors.forename: Pieter C
authors.initials: PC
authors.lastname: Smits
authors.forename: Pim
authors.initials: P
authors.lastname: de Feyter
authors.forename: Jurghen
authors.initials: J
authors.lastname: Ligthart
authors.forename: Ron T
authors.initials: RT
authors.lastname: van Domburg
authors.forename: Patrick W
authors.initials: PW
authors.lastname: Serruys
mesh_terms: D000368:Aged; D019917:Blood Vessel Prosthesis Implantation; D001918:Brachytherapy; D005260:Female; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000188:drug therapy* / Q000517:prevention & control / Q000532:radiotherapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D055502:Secondary Prevention; D020123:Sirolimus / Q000008:administration & dosage* / Q000627:therapeutic use*; D015607:Stents; D017211:Treatment Failure
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus